| Sub Cat | Immunogen | Isotype | Application | Affinity | |
|---|---|---|---|---|---|
| V3S-1124-YC142 | Human CD4 molecule | IgG4 | Block | ||
| V3S-0622-YC1302 | IgG | Neut; ELISA; IF; IP; FuncS; FC; IHC | |||
| V3S-0622-YC1303 | IgG | IF; IP; Neut; FuncS; ELISA; FC; ICC | |||
| V3S-0622-YC1304 | IgG | FuncS | |||
| V3S-0622-YC4332 | P815 mastocytoma ce11stransfected with human CD4 cDNA | IgG | WB; FuncS; IF; Neut; ELISA; FC; IP | ||
| V3S-0522-YC3185 | Recombinant human CD4 | IgG | ELISA; FC; ADCC; CDC | 61.4 pM | |
| V3S-0522-YC3187 | Recombinant human CD4 | IgG | ELISA; FC; ADCC; CDC | 0.651 nM | |
| V3S-0522-YC3188 | Recombinant human CD4 | IgG | ELISA; FC; ADCC; CDC | 0.2 nM | |
| V3S-0522-YC3189 | Recombinant human CD4 | IgG | ELISA; FC | 19.5 pM | |
| V3S-0522-YC3190 | Recombinant human CD4 | IgG | ELISA; FC | 7.52 pM | |
| V3S-0522-YC3191 | Recombinant human CD4 | IgG | ELISA; FC | 12.6 pM | |
| V3S-0522-YC3192 | Recombinant human CD4 | IgG | ELISA; FC | 24.8 pM | |
| V3S-0522-YC508 | IgG1 kappa | ELISA; FuncS | |||
| V3S-0522-YC5284 | IgG4 | FC; SPR; ELISA | |||
| V3S-0522-YC5287 | IgG1 kappa | ELISA | |||
| V3S-0522-YC5288 | IgG1 | ELISA | |||
| V3S-0522-YC5290 | IgG3 kappa | ELISA; SPR | |||
| V3S-0522-YC5291 | IgG | ELISA; SPR | |||
| V3S-0522-YC5292 | IgG | ELISA | |||
| V3S-0522-YC7281 | Human CD4 molecule | IgG | WB; ELISA; FuncS | ||
| V3S-0522-YC7641 | Human CD4 molecule | IgG | WB; ELISA; FuncS | ||
| V3S-0622-YC3015 | IgG | ELISA | |||
| V3S-0622-YC3016 | IgG | ELISA | |||
| V3S-1022-YC1923 | IgG1 | ELISA; FC | 62 pM | ||
| V3S-1022-YC1924 | IgG1 | ELISA; FC | 65 pM |
| Description | This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize CD4 molecule. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Immunogen | Human CD4 molecule |
| Isotype | IgG4 |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | Block |
| Application Notes | The antibody is recommended for detection of CD4 by Block assay. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
